BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24827764)

  • 1. Peripheral B-cell phenotype and BAFF levels are associated with HLA immunization in patients awaiting kidney transplantation.
    Snanoudj R; Candon S; Roelen DL; Jais JP; Claas FH; Legendre C; Chatenoud L
    Transplantation; 2014 May; 97(9):917-24. PubMed ID: 24827764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival.
    Friebus-Kardash J; Wilde B; Keles D; Heinold A; Kribben A; Witzke O; Heinemann FM; Eisenberger U
    Transpl Immunol; 2018 Apr; 47():10-17. PubMed ID: 29277566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant soluble B-cell activating factor kinetics in pediatric recipients of first kidney allograft.
    Comoli P; Quartuccio G; Cioni M; Parodi A; Nocera A; Basso S; Fontana I; Magnasco A; Sioli V; Guido I; Klersy C; Zecca M; Cardillo M; Ghiggeri GM; Ginevri F
    Transplantation; 2015 Jan; 99(1):243-9. PubMed ID: 25033258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status.
    Karahan GE; Kekik C; Oguz FS; Onal AE; Bakkaloğlu H; Calişkan YK; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
    Ren Fail; 2010 Jan; 32(3):380-3. PubMed ID: 20370456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant.
    Snanoudj R; Claas FH; Heidt S; Legendre C; Chatenoud L; Candon S
    Kidney Int; 2015 Jun; 87(6):1230-40. PubMed ID: 25565312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft.
    Slavcev A; Brozova J; Slatinska J; Sekerkova Z; Honsova E; Skibova J; Striz I; Viklicky O
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):47-53. PubMed ID: 28083608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients.
    Kopchaliiska D; Zachary AA; Montgomery RA; Leffell MS
    Transplantation; 2009 May; 87(9):1394-401. PubMed ID: 19424042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Cell Activating Factor (BAFF) in Long-term Kidney Transplant Recipients Is Not a Prognostic Marker for Allograft Dysfunction or Survival.
    Kościelska-Kasprzak K; Bartoszek D; Myszka M; Kamińska D; Boratyńska M; Krajewska M; Klinger M
    Transplant Proc; 2018; 50(6):1750-1754. PubMed ID: 30056894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Pretransplant BAFF Levels and B-cell Subset Polarized towards a Memory Phenotype as Predictive Biomarkers for Antibody-Mediated Rejection.
    Irure-Ventura J; San Segundo D; Rodrigo E; Merino D; Belmar-Vega L; Ruiz San Millán JC; Valero R; Benito A; López-Hoyos M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibition by bortezomib: effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation.
    Guthoff M; Schmid-Horch B; Weisel KC; Häring HU; Königsrainer A; Heyne N
    Transpl Immunol; 2012 Jun; 26(4):171-5. PubMed ID: 22326708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.
    d'Arbonneau F; Pers JO; Devauchelle V; Pennec Y; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jan; 54(1):115-26. PubMed ID: 16385503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients.
    Min JW; Kim KW; Kim BM; Doh KC; Choi MS; Choi BS; Park CW; Yang CW; Kim YS; Oh EJ; Chung BH
    PLoS One; 2016; 11(9):e0162964. PubMed ID: 27631619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of de novo human leukocyte antigen and major histocompatibility complex class I chain-related gene-A antibodies and proteinuria with graft survival 5 years after renal transplantation.
    Zhang LW; Peng ZG; Xian WH; Cui XQ; Sun HB; Li EG; Geng LN; Zhao P; Tian J
    Transplant Proc; 2013 Nov; 45(9):3249-53. PubMed ID: 24182794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Mazanowska O; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Szyber P; Patrzałek D; Klinger M
    Transplant Proc; 2013 May; 45(4):1462-5. PubMed ID: 23726597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-Cell-Activating Factor Levels Are Associated With Antibody-Mediated Histological Damage in Kidney Transplantation.
    Sango C; Merino D; San Segundo D; Rodrigo E; Lopez-Hoyos M; Benito A; Ángeles Ramos M; Gómez-Román J; Arias M
    Transplant Proc; 2016 Nov; 48(9):2910-2912. PubMed ID: 27932105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
    Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.